by Leslie Smal
UnitedHealth Group began the first quarter of 2021 on a high
note, reporting earnings per share (EPS) and a medical loss ratio (MLR) that
both beat the Wall Street consensus estimate and saying it expects to achieve
greater full-year earnings than it previously estimated. However, executives
warned that the majority of the unfavorable COVID-19-related impact they're
expecting will transpire in the second half of the year.
UnitedHealth expects roughly 70% of the predicted COVID-related $1.80 EPS hit
to occur in the back half of the year, Chief Financial Officer John Rex said
during an April 15 conference call to discuss the company's financial results.
He said that projection is based on UnitedHealth's prediction that as the year
wears on and vaccination rates rise, people will increasingly be able to access
higher-acuity, previously deferred care.
UnitedHealth's adjusted first-quarter EPS of $5.31 handily beat the Wall Street
consensus estimate of $4.39, and its MLR of 80.9% topped the Street's
prediction of 82.8%. The MLR result "likely speaks to lower core
utilization patterns, particularly early in the quarter as COVID spiked,"
Citi analyst Ralph Giacobbe observed in an April 15 note to investors. The
company also raised its 2021 EPS guidance to a range of $18.10 to $18.60,
compared with prior guidance of $17.75 to $18.25.
"We view the results as a good start to the year, and the guidance raise
as prudent all things considered, which should allow the stock to grind
higher," Giacobbe wrote.
The business strategy surrounding various Optum divisions took center stage
during the company's earnings call — especially OptumCare's move toward
value-based care models.
"Of the 4 million patients who OptumCare serves in some form of
accountable arrangement today, 2 million are being served under fully capitated
arrangements, and this demonstrates strong growth and progress — but OptumCare
serves 20 million patients in total, which is one reason why we view the
potential of OptumCare as only beginning to be harnessed," new
UnitedHealth Group CEO Andrew Witty said.
Witty also expressed excitement about the analytics division OptumInsight,
which saw a slowdown in new business prospects amid the pandemic but now has a
"very exciting" pipeline of new business.
No comments:
Post a Comment